+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lifestyle Drugs Market Research Report by Therapeutic Type (Dermatology, Insomnia, Obesity, Sexual Dysfunction, and Smoking), by Form (Creams, Gels, Oral Syrups, Parenteral, and Tablets), by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5305529
  • Report
  • March 2021
  • Region: Global
  • 189 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
1 of 4
The Global Lifestyle Drugs Market to Grow USD 22,536.57 Million by 2025, at a CAGR of 4.79%

FEATURED COMPANIES

  • Amgen Inc.
  • AstraZeneca plc
  • Biocon Limited
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • MORE
Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Lifestyle Drugs Market is expected to grow from USD 17,832.56 Million in 2020 to USD 22,536.57 Million by the end of 2025.
2. The Global Lifestyle Drugs Market is expected to grow from EUR 15,635.93 Million in 2020 to EUR 19,760.49 Million by the end of 2025.
3. The Global Lifestyle Drugs Market is expected to grow from GBP 13,900.37 Million in 2020 to GBP 17,567.12 Million by the end of 2025.
4. The Global Lifestyle Drugs Market is expected to grow from JPY 1,903,186.86 Million in 2020 to JPY 2,405,223.09 Million by the end of 2025.
5. The Global Lifestyle Drugs Market is expected to grow from AUD 25,895.26 Million in 2020 to AUD 32,726.09 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Lifestyle Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Therapeutic Type, the Lifestyle Drugs Market is examined across Dermatology, Insomnia, Obesity, Sexual Dysfunction, Smoking, and Women's Health.

Based on Form, the Lifestyle Drugs Market is examined across Creams, Gels, Oral Syrups, Parenteral, and Tablets.

Based on Distribution, the Lifestyle Drugs Market is examined across Hospital Pharmacies, Online Channels, and Retail Pharmacies.

Based on Geography, the Lifestyle Drugs Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Lifestyle Drugs Market including Amgen Inc., AstraZeneca plc, Biocon Limited, Dr. Reddy's Laboratories, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., d.b.a., Pfizer Inc., Procter & Gamble Company, and Teva Pharmaceutical Industries Ltd..

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Lifestyle Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Lifestyle Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Lifestyle Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Lifestyle Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Lifestyle Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Lifestyle Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Lifestyle Drugs Market?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • AstraZeneca plc
  • Biocon Limited
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Therapeutic Type Outlook
3.4. Form Outlook
3.5. Distribution Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Lifestyle Drugs Market, By Therapeutic Type
6.1. Introduction
6.2. Dermatology
6.3. Insomnia
6.4. Obesity
6.5. Sexual Dysfunction
6.6. Smoking
6.7. Women’s Health

7. Global Lifestyle Drugs Market, By Form
7.1. Introduction
7.2. Creams
7.3. Gels
7.4. Oral Syrups
7.5. Parenteral
7.6. Tablets

8. Global Lifestyle Drugs Market, By Distribution
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Channels
8.4. Retail Pharmacies

9. Americas Lifestyle Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Lifestyle Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Lifestyle Drugs Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Amgen Inc.
13.2. AstraZeneca plc
13.3. Biocon Limited
13.4. Dr. Reddy's Laboratories
13.5. Eli Lilly and Company
13.6. GlaxoSmithKline plc
13.7. Johnson & Johnson
13.8. Merck & Co., Inc., d.b.a.
13.9. Pfizer Inc.
13.10. Procter & Gamble Company
13.11. Teva Pharmaceutical Industries Ltd.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
Figure 1. Global Lifestyle Drugs Market: Research Process
Figure 2. Global Lifestyle Drugs Market: Research Execution
Figure 3. Global Lifestyle Drugs Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Lifestyle Drugs Market Size, by Therapeutic Type, 2020 (USD Million)
Figure 5. Global Lifestyle Drugs Market Size, by Form, 2020 (USD Million)
Figure 6. Global Lifestyle Drugs Market Size, by Distribution, 2020 (USD Million)
Figure 7. Global Lifestyle Drugs Market Size, by Geography, 2020 (USD Million)
Figure 8. Global Lifestyle Drugs Market Size, 2018-2025 (USD Million)
Figure 9. Global Lifestyle Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 10. Global Lifestyle Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 11. Competitive Strategic Window for Global Lifestyle Drugs Market Size, by Geography, 2025
Figure 12. Global Lifestyle Drugs Market: Market Dynamics
Figure 13. Global Lifestyle Drugs Market: Porters Five Forces Analysis
Figure 14. Global Lifestyle Drugs Market Size, by Therapeutic Type, 2020 Vs 2025 (%)
Figure 15. Global Lifestyle Drugs Market Size, by Therapeutic Type, 2020 Vs 2025 (USD Million)
Figure 16. Competitive Strategic Window for Global Lifestyle Drugs Market Size, by Therapeutic Type, 2025
Figure 17. Global Lifestyle Drugs Market Size, by Dermatology, 2020 Vs 2025 (USD Million)
Figure 18. Global Lifestyle Drugs Market Size, by Insomnia, 2020 Vs 2025 (USD Million)
Figure 19. Global Lifestyle Drugs Market Size, by Obesity, 2020 Vs 2025 (USD Million)
Figure 20. Global Lifestyle Drugs Market Size, by Sexual Dysfunction, 2020 Vs 2025 (USD Million)
Figure 21. Global Lifestyle Drugs Market Size, by Smoking, 2020 Vs 2025 (USD Million)
Figure 22. Global Lifestyle Drugs Market Size, by Women's Health, 2020 Vs 2025 (USD Million)
Figure 23. Global Lifestyle Drugs Market Size, by Form, 2020 Vs 2025 (%)
Figure 24. Global Lifestyle Drugs Market Size, by Form, 2020 Vs 2025 (USD Million)
Figure 25. Competitive Strategic Window for Global Lifestyle Drugs Market Size, by Form, 2025
Figure 26. Global Lifestyle Drugs Market Size, by Creams, 2020 Vs 2025 (USD Million)
Figure 27. Global Lifestyle Drugs Market Size, by Gels, 2020 Vs 2025 (USD Million)
Figure 28. Global Lifestyle Drugs Market Size, by Oral Syrups, 2020 Vs 2025 (USD Million)
Figure 29. Global Lifestyle Drugs Market Size, by Parenteral, 2020 Vs 2025 (USD Million)
Figure 30. Global Lifestyle Drugs Market Size, by Tablets, 2020 Vs 2025 (USD Million)
Figure 31. Global Lifestyle Drugs Market Size, by Distribution, 2020 Vs 2025 (%)
Figure 32. Global Lifestyle Drugs Market Size, by Distribution, 2020 Vs 2025 (USD Million)
Figure 33. Competitive Strategic Window for Global Lifestyle Drugs Market Size, by Distribution, 2025
Figure 34. Global Lifestyle Drugs Market Size, by Hospital Pharmacies, 2020 Vs 2025 (USD Million)
Figure 35. Global Lifestyle Drugs Market Size, by Online Channels, 2020 Vs 2025 (USD Million)
Figure 36. Global Lifestyle Drugs Market Size, by Retail Pharmacies, 2020 Vs 2025 (USD Million)
Figure 37. Americas Lifestyle Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 38. Americas Lifestyle Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 39. Competitive Strategic Window for Americas Lifestyle Drugs Market Size, by Geography, 2025
Figure 40. Argentina Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 41. Brazil Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 42. Canada Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 43. Mexico Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 44. United States Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 45. Asia-Pacific Lifestyle Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 46. Asia-Pacific Lifestyle Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 47. Competitive Strategic Window for Asia-Pacific Lifestyle Drugs Market Size, by Geography, 2025
Figure 48. Australia Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 49. China Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. India Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. Indonesia Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. Japan Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. Malaysia Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 54. Philippines Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 55. South Korea Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 56. Thailand Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 57. Europe, Middle East & Africa Lifestyle Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 58. Europe, Middle East & Africa Lifestyle Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 59. Competitive Strategic Window for Europe, Middle East & Africa Lifestyle Drugs Market Size, by Geography, 2025
Figure 60. France Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 61. Germany Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 62. Italy Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 63. Netherlands Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 64. Qatar Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 65. Russia Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 66. Saudi Arabia Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. South Africa Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 68. Spain Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 69. United Arab Emirates Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 70. United Kingdom Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 71. Global Lifestyle Drugs Market: Fpnv Positioning Matrix
Figure 72. Global Lifestyle Drugs Market: Market Share Analysis
Figure 73. Global Lifestyle Drugs Market: Competitor SWOT Analysis
Figure 74. Competitive Scenario Analysis in Global Lifestyle Drugs Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Lifestyle Drugs Market Size, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 3. Global Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 4. Global Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 5. Global Lifestyle Drugs Market Size, by Dermatology, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 6. Global Lifestyle Drugs Market Size, by Insomnia, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 7. Global Lifestyle Drugs Market Size, by Obesity, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 8. Global Lifestyle Drugs Market Size, by Sexual Dysfunction, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 9. Global Lifestyle Drugs Market Size, by Smoking, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 10. Global Lifestyle Drugs Market Size, by Women's Health, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 11. Global Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 12. Global Lifestyle Drugs Market Size, by Creams, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 13. Global Lifestyle Drugs Market Size, by Gels, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 14. Global Lifestyle Drugs Market Size, by Oral Syrups, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 15. Global Lifestyle Drugs Market Size, by Parenteral, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 16. Global Lifestyle Drugs Market Size, by Tablets, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 17. Global Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 18. Global Lifestyle Drugs Market Size, by Hospital Pharmacies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 19. Global Lifestyle Drugs Market Size, by Online Channels, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 20. Global Lifestyle Drugs Market Size, by Retail Pharmacies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 21. Americas Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 22. Americas Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 23. Americas Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 24. Americas Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 25. Argentina Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 26. Argentina Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 27. Argentina Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 28. Brazil Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 29. Brazil Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 30. Brazil Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 31. Canada Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 32. Canada Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 33. Canada Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 34. Mexico Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 35. Mexico Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 36. Mexico Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 37. United States Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 38. United States Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 39. United States Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 40. Asia-Pacific Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 41. Asia-Pacific Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 42. Asia-Pacific Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 43. Asia-Pacific Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 44. Australia Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 45. Australia Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 46. Australia Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 47. China Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 48. China Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 49. China Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 50. India Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 51. India Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 52. India Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 53. Indonesia Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 54. Indonesia Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 55. Indonesia Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 56. Japan Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 57. Japan Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 58. Japan Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 59. Malaysia Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 60. Malaysia Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 61. Malaysia Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 62. Philippines Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 63. Philippines Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 64. Philippines Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 65. South Korea Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 66. South Korea Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 67. South Korea Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 68. Thailand Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 69. Thailand Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 70. Thailand Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 71. Europe, Middle East & Africa Lifestyle Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 72. Europe, Middle East & Africa Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 73. Europe, Middle East & Africa Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 74. Europe, Middle East & Africa Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 75. France Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 76. France Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 77. France Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 78. Germany Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 79. Germany Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 80. Germany Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 81. Italy Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 82. Italy Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 83. Italy Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 84. Netherlands Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 85. Netherlands Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 86. Netherlands Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 87. Qatar Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 88. Qatar Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 89. Qatar Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 90. Russia Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 91. Russia Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 92. Russia Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 93. Saudi Arabia Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 94. Saudi Arabia Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 95. Saudi Arabia Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 96. South Africa Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 97. South Africa Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 98. South Africa Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 99. Spain Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 100. Spain Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 101. Spain Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 102. United Arab Emirates Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 103. United Arab Emirates Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 104. United Arab Emirates Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 105. United Kingdom Lifestyle Drugs Market Size, by Therapeutic Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 106. United Kingdom Lifestyle Drugs Market Size, by Form, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 107. United Kingdom Lifestyle Drugs Market Size, by Distribution, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 108. Global Lifestyle Drugs Market: Scores
Table 109. Global Lifestyle Drugs Market: Business Strategy
Table 110. Global Lifestyle Drugs Market: Product Satisfaction
Table 111. Global Lifestyle Drugs Market: Ranking
Table 112. Global Lifestyle Drugs Market: Merger & Acquisition
Table 113. Global Lifestyle Drugs Market: Agreement, Collaboration, & Partnership
Table 114. Global Lifestyle Drugs Market: New Product Launch & Enhancement
Table 115. Global Lifestyle Drugs Market: Investment & Funding
Table 116. Global Lifestyle Drugs Market: Award, Recognition, & Expansion
Table 117. Global Lifestyle Drugs Market: License & Pricing
Note: Product cover images may vary from those shown
3 of 4
  • Amgen Inc.
  • AstraZeneca plc
  • Biocon Limited
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc., d.b.a.
  • Pfizer Inc.
  • Procter & Gamble Company
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll